2150 St. ElzEar Boulevard West
Laval, QC H7L 4A8
Canada
514 744 6792
https://www.bauschhealth.com
Sector(es): Healthcare
Industria: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 20,270
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Thomas J. Appio | CEO & Director | 2.55M | N/D | 1962 |
Mr. John S. Barresi | Senior VP, Controller, Chief Accounting Officer & Interim CFO | 741.36k | N/D | 1973 |
Ms. Seana Carson | Executive VP & General Counsel | 811.92k | N/D | 1973 |
Mr. Mirza Dautbegovic | Executive VP & COO | N/D | N/D | N/D |
Ms. Kathleen Fitzpatrick | Executive VP and Chief HR & Communications Officer | N/D | N/D | N/D |
Mr. Josh Coyle | Senior Vice President of Sales & Salix | N/D | N/D | N/D |
Dr. Tage Ramakrishna M.D. | Chief Medical Officer and President of R&D | N/D | N/D | 1974 |
Mr. Jeff Hartness | Executive VP of Market Access, Commercial Operations, Neurology, Generics & Government Affairs | N/D | N/D | N/D |
Dr. Graham Jackson | Senior VP & Chief Quality Officer | N/D | N/D | N/D |
Mr. Cees Heiman | Senior Vice President of Europe & Canada | N/D | N/D | N/D |
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company in the United States and internationally. It develops, manufactures, and markets a range of products primarily in gastroenterology, hepatology, neurology, dermatology, international pharmaceuticals, over-the-counter (OTC) products, aesthetic medical devices, and eye health. The company operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The Salix segment provides gastroenterology products in the United States. The International segment sells aesthetic medical devices, branded pharmaceuticals, generic pharmaceuticals, and OTC products internationally. The Solta Medical segment engages in the sale of aesthetic medical devices. The Diversified segment offers pharmaceutical products in the areas of neurology and certain other therapeutic classes; generic products; ortho dermatologic; and dentistry products in the United States. The Bausch + Lomb segment offers products in the areas of vision care, surgical, and ophthalmic pharmaceuticals products. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
La calificación ISS Governance QuickScore de Bausch Health Companies Inc. a partir del 1 de julio de 2024 es 3. Las puntuaciones principales son Auditoría: 7; Junta: 2; Derechos del accionista: 3; Compensación: 5.